Division of Neuropediatrics and Developmental Medicine, University Children's Hospital Basel, Basel, Switzerland.
Epilepsia. 2012 Feb;53(2):325-33. doi: 10.1111/j.1528-1167.2011.03377.x. Epub 2012 Jan 13.
Children with epilepsy have a significant risk for attention-deficit/hyperactivity disorder (ADHD), which is often accompanied by deficits in working memory performance. However, it is not yet clear whether there are specific differences in the underlying mechanisms of working memory capability between children with epilepsy-related ADHD and those with developmental ADHD. There is evidence that methylphenidate can improve the behavioral difficulties in children with developmental ADHD. Whether this medication has the same effect on ADHD symptoms in patients with epilepsy is not yet well understood. The aim of the present study is, therefore, to evaluate whether boys with epilepsy-related ADHD and developmental ADHD share a common behavioral, pharmacoresponsive, and neurofunctional pathophysiology.
Seventeen boys with diagnosed combined epilepsy/ADHD, 15 boys with developmental ADHD, and 15 healthy controls (aged 8-14 years) performed on working memory tasks (N-back) while brain activation was recorded using functional magnetic resonance imaging. Each patient was tested twice: once after the intake of methylphenidate and once without in a counterbalanced order.
On a behavioral level, we show that boys with epilepsy-related ADHD as well as those with developmental ADHD performed similarly poorly on tasks with high cognitive load when compared to healthy controls, and that intake of methylphenidate improved performance almost to normal levels in both ADHD groups. On the functional level, both patient groups showed similar reductions of activation in all relevant parts of the functional network of working memory when compared to controls. Of interest, intake of methylphenidate did not significantly alter this activity pattern.
Our data show strong similarities between epilepsy-related and developmental ADHD on the behavioral, pharmacoresponsive, and neural level, favoring the view that ADHD with and without epilepsy shares a common underlying neurobehavioral pathophysiology.
患有癫痫的儿童存在明显的注意力缺陷多动障碍(ADHD)风险,而 ADHD 常伴有工作记忆表现缺陷。然而,目前尚不清楚癫痫相关 ADHD 儿童和发育性 ADHD 儿童的工作记忆能力的潜在机制是否存在特异性差异。有证据表明,哌醋甲酯可以改善发育性 ADHD 儿童的行为困难。这种药物对癫痫患者的 ADHD 症状是否有相同的影响尚不清楚。因此,本研究的目的是评估癫痫相关 ADHD 儿童和发育性 ADHD 儿童是否具有共同的行为、药物反应和神经功能病理生理学。
17 名被诊断为合并癫痫/ADHD 的男孩、15 名患有发育性 ADHD 的男孩和 15 名健康对照者(年龄 8-14 岁)在执行工作记忆任务(N-back)时记录大脑激活情况,使用功能磁共振成像。每位患者均接受两次测试:一次是在服用哌醋甲酯后,一次是在没有药物的情况下,以平衡的方式进行。
在行为层面,我们发现癫痫相关 ADHD 儿童和发育性 ADHD 儿童在高认知负荷任务中的表现与健康对照组相似,且哌醋甲酯的摄入几乎可使两个 ADHD 组的表现提高至正常水平。在功能层面,与对照组相比,两个患者组在工作记忆功能网络的所有相关部分的激活均显示出相似的降低。有趣的是,哌醋甲酯的摄入并未显著改变这种活动模式。
我们的数据表明,癫痫相关 ADHD 和发育性 ADHD 在行为、药物反应和神经水平上具有很强的相似性,支持 ADHD 伴或不伴癫痫具有共同的潜在神经行为病理生理学的观点。